Elisabetta Bugianesi
Impact in
- Hepatology top 0.05%
- Liver Disease and Transplantation
- Hepatitis C virus research
- Epidemiology top 0.01%
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 247
- Liver Disease Diagnosis and Treatment 235
- Hepatology 73
- Liver Disease and Transplantation 36
- Hepatitis C virus research 20
- Hepatocellular Carcinoma Treatment and Prognosis 16
- Liver Diseases and Immunity 16
- Co-authors
- Giulio Marchesini (67 shared papers)Ester Vanni (31 shared papers)Zobair M. Younossi (10 shared papers)Arthur J. McCullough (6 shared papers)Jacob George (11 shared papers)Quentin M. Anstee (28 shared papers)Gabriele Forlani (8 shared papers)Nazario Melchionda (6 shared papers)
- Journals
- Journal of Hepatology (39 papers)Hepatology (28 papers)Digestive and Liver Disease (26 papers)Liver International (12 papers)Journal of Clinical Medicine (11 papers)
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Elisabetta Bugianesi
288 papers receiving 34.3k citations
Elisabetta Bugianesi's Hit Papers
Peers
Comparison fields: 5 of 158
- Hepatology 6.7k
- Epidemiology 24.8k
- Endocrinology, Diabetes and Metabolism 9.2k
- Pathology and Forensic Medicine 2.8k
- Physiology 3.6k
Countries citing papers authored by Elisabetta Bugianesi
This map shows the geographic impact of Elisabetta Bugianesi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabetta Bugianesi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabetta Bugianesi more than expected).
Fields of papers citing papers by Elisabetta Bugianesi
This network shows the impact of papers produced by Elisabetta Bugianesi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabetta Bugianesi. The network helps show where Elisabetta Bugianesi may publish in the future.
Co-authors
The 25 scholars most cited alongside Elisabetta Bugianesi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 306 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention Hit paper breakdown → | 2017 | 4022 |
| 2 | Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome Hit paper breakdown → | 2003 | 2225 |
| 3 | Nonalcoholic Fatty Liver Disease Hit paper breakdown → | 2001 | 2149 |
| 4 | Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Hit paper breakdown → | 2018 | 1402 |
| 5 | Association of nonalcoholic fatty liver disease with insulin resistance Hit paper breakdown → | 1999 | 1314 |
| 6 | Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma Hit paper breakdown → | 2002 | 1200 |
| 7 | EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) Hit paper breakdown → | 2024 | 758 |
| 8 | Insulin Resistance: A Metabolic Pathway to Chronic Liver Disease * Hit paper breakdown → | 2005 | 718 |
| 9 | Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease Hit paper breakdown → | 2013 | 666 |
| 10 | Nonalcoholic fatty liver disease Hit paper breakdown → | 2015 | 655 |
| 11 | Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates Hit paper breakdown → | 2018 | 624 |
| 12 | Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms Hit paper breakdown → | 2005 | 617 |
| 13 | Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis Hit paper breakdown → | 2016 | 610 |
| 14 | A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease Hit paper breakdown → | 2005 | 570 |
| 15 | Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis Hit paper breakdown → | 2015 | 562 |
| 16 | Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes Hit paper breakdown → | 2008 | 549 |
| 17 | Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease† Hit paper breakdown → | 2005 | 510 |
| 18 | Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease† Hit paper breakdown → | 2010 | 509 |
| 19 | Global epidemiology of cirrhosis — aetiology, trends and predictions Hit paper breakdown → | 2023 | 453 |
| 20 | Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis Hit paper breakdown → | 2024 | 443 |
About Elisabetta Bugianesi
Elisabetta Bugianesi is a scholar working on Epidemiology, Hepatology, Endocrinology, Diabetes and Metabolism, Physiology and Molecular Biology, having authored 306 papers that have together received 35.2k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (235 papers), Diet, Metabolism, and Disease (64 papers), Liver Disease and Transplantation (36 papers), Diet and metabolism studies (22 papers), Hepatitis C virus research (20 papers), Pancreatitis Pathology and Treatment (18 papers), Hepatocellular Carcinoma Treatment and Prognosis (16 papers) and Liver Diseases and Immunity (16 papers). The work is most often cited by research in Hepatology (6.7k citations), Epidemiology (24.8k citations), Endocrinology, Diabetes and Metabolism (9.2k citations), Pathology and Forensic Medicine (2.8k citations) and Physiology (3.6k citations). Elisabetta Bugianesi has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Giulio Marchesini, Ester Vanni, Zobair M. Younossi, Arthur J. McCullough, Jacob George, Quentin M. Anstee, Gabriele Forlani, Nazario Melchionda, M. Marietti and Mohammed Eslam. Their work appears in journals such as Journal of Hepatology, Hepatology, Digestive and Liver Disease, Liver International and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.